{"id":"W4295083464","doi":"10.1111/bjd.21867","title":"Safety of tralokinumab in adult patients with moderate-to-severe atopic dermatitis: pooled analysis of five randomized, double-blind, placebo-controlled phase II and phase III trials","year":2022,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research","funders":"Manchester Biomedical Research Centre; LEO Pharma; LEO Pharma Research Foundation; National Institute for Health and Care Research","keywords":"Placebo; Medicine; Atopic dermatitis; Internal medicine; Adverse effect; Upper respiratory tract infection; Confidence interval; Randomized controlled trial; Gastroenterology; Immunology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009639637,0.0002493924,0.0055221,0.001217384,0.0001809883,0.00001597078,0.0002018369,0.0001440712,0.0004390828],"category_scores_gemma":[0.0009253863,0.0002238872,0.0006866874,0.0007354581,0.0002609834,0.000189876,0.00008433512,0.0004376598,3.015782e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005534073,"about_ca_system_score_gemma":0.0003391831,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001054078,"about_ca_topic_score_gemma":0.000114617,"domain_scores_codex":[0.9941711,0.001697544,0.003041178,0.0002621514,0.0005075927,0.0003204404],"domain_scores_gemma":[0.9959438,0.001058438,0.001909523,0.0001946646,0.0006438678,0.0002497349],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9689614,0.003939632,0.006961648,0.0001206573,0.009709843,0.00323911,0.001017329,0.003251123,0.00001047097,0.00005223871,0.0007706328,0.001965872],"study_design_scores_gemma":[0.970111,0.0006457554,0.001757401,0.0002890135,0.01139315,0.01066233,0.0005339184,0.004131262,0.0001957158,0.00006877164,0.00002001032,0.0001917495],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9930134,0.002587102,0.0008860481,0.0008556079,0.0001093868,0.002119622,0.0002815482,0.000008788395,0.0001385112],"genre_scores_gemma":[0.998497,0.0003337802,0.0002896591,0.0005349205,0.00001556771,0.0001419041,0.0001403247,0.00001863127,0.00002820292],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007423219,"threshold_uncertainty_score":0.9129857,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01201276640846608,"score_gpt":0.2885681162650966,"score_spread":0.2765553498566305,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}